Selected article for: "clinical setting and International license"

Author: Denisa Bojkova; Jake E. McGreig; Katie-May McLaughlin; Stuart G. Masterson; Marek Widera; Verena Krähling; Sandra Ciesek; Mark N. Wass; Martin Michaelis; Jindrich Cinatl
Title: SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
  • Document date: 2020_4_5
  • ID: gpr86lxe_44
    Snippet: identified novel candidate therapies based on approved drugs that can be readily 469 tested in a clinical setting. Absorbance-based quantification of the RNA yield was performed using the 566 Genesys 10S UV-Vis Spectrophotometer (Thermo Scientific). RNA was subjected to 567 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.o.....
    Document: identified novel candidate therapies based on approved drugs that can be readily 469 tested in a clinical setting. Absorbance-based quantification of the RNA yield was performed using the 566 Genesys 10S UV-Vis Spectrophotometer (Thermo Scientific). RNA was subjected to 567 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.03.024257 doi: bioRxiv preprint

    Search related documents:
    Co phrase search for related documents
    • novel candidate and RNA yield: 1